{"id":"urinary-hcg","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS) in females"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"This is a naturally-derived gonadotropin extracted and purified from the urine of pregnant women. It acts as a luteinizing hormone (LH) analog, binding to LH receptors on Leydig cells in males and theca cells in females to stimulate testosterone and progesterone production respectively. It is used clinically to support reproductive function and hormone replacement.","oneSentence":"Urinary-hCG is a human chorionic gonadotropin (hCG) derived from urine that stimulates hormone production in reproductive tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:53:10.570Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypogonadism in males"},{"name":"Infertility associated with hypogonadotropic hypogonadism"},{"name":"Ovulation induction in females with infertility"}]},"trialDetails":[{"nctId":"NCT04886726","phase":"PHASE1","title":"PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2021-12-23","conditions":"Graft Versus Host Disease","enrollment":18},{"nctId":"NCT07372859","phase":"NA","title":"Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners","status":"NOT_YET_RECRUITING","sponsor":"French Cardiology Society","startDate":"2026-03-22","conditions":"Healthy Volunteer","enrollment":120},{"nctId":"NCT06906042","phase":"","title":"Multimodal Cardiovascular and Hepatic Population Imaging","status":"RECRUITING","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2025-09-15","conditions":"Healthy Volunteers, Imaging Evaluation","enrollment":2400},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT06934785","phase":"NA","title":"LE + CC vs. LE for Ovulation Induction","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-04-28","conditions":"Letrozole, Clomiphene Citrate, Ovulation Disorder","enrollment":600},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06906133","phase":"","title":"Sleep Quality and the Menstrual Cycle","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Akureyri","startDate":"2025-03-01","conditions":"Sleep Quality","enrollment":60},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT05458778","phase":"","title":"Detection of Urinary Human Chorionic Gonadotropin (hCG)","status":"UNKNOWN","sponsor":"Quanovate Tech Inc.","startDate":"2022-06-29","conditions":"Pregnancy Detection","enrollment":200},{"nctId":"NCT04168892","phase":"","title":"Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response","status":"COMPLETED","sponsor":"Andros Day Surgery Clinic","startDate":"2019-09-20","conditions":"Ovarian Response","enrollment":160},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT04824118","phase":"","title":"Clotting Parameters After Medical Abortion","status":"COMPLETED","sponsor":"NHS Lothian","startDate":"2021-03-26","conditions":"Abortion Early, Abortion, Complete, Abortion, Second Trimester","enrollment":45},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT04265495","phase":"","title":"Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?","status":"UNKNOWN","sponsor":"Al Baraka Fertility Hospital","startDate":"2020-02-09","conditions":"IVF","enrollment":600},{"nctId":"NCT03713736","phase":"NA","title":"Papillomavirus Load in Rheumatic Inflammatory Diseases","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2020-01-09","conditions":"Spondyloarthritis, Rhumatoid Arthisis","enrollment":385},{"nctId":"NCT03264820","phase":"NA","title":"Study of the Reproducibility of Laser Measurement in the Detection of Digital Obstructive Arterial Disease (DOAD)","status":"TERMINATED","sponsor":"Rennes University Hospital","startDate":"2017-12-06","conditions":"Vascular Diseases","enrollment":17},{"nctId":"NCT01058252","phase":"","title":"Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF","status":"UNKNOWN","sponsor":"Galaxy Pharma (Pvt) Limited","startDate":"2021-05","conditions":"Primary Infertility, Secondary Infertility, Low Responders","enrollment":30},{"nctId":"NCT04301973","phase":"NA","title":"Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development","status":"COMPLETED","sponsor":"Danone Global Research & Innovation Center","startDate":"2020-09-02","conditions":"Healthy Subjects","enrollment":18},{"nctId":"NCT04679688","phase":"NA","title":"Comparison of Follicle Diameter on hCG Day and Follicle Diameters on OPU (Oocyte Pick up) Day and the Effect of Follicle Diameters on Embryo Development and Pregnancy Outcomes","status":"UNKNOWN","sponsor":"Acibadem University","startDate":"2020-12-20","conditions":"HCG Day Follicle Diameter, Reproduction Results","enrollment":100},{"nctId":"NCT03877185","phase":"","title":"A New Revolutionary 3-Injection- Protocol in Infertile Women","status":"UNKNOWN","sponsor":"Assisting Nature","startDate":"2018-07-01","conditions":"Infertility, Female","enrollment":100},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT01094496","phase":"PHASE2","title":"A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The \"N-ABLE\" Study)","status":"TERMINATED","sponsor":"Celldex Therapeutics","startDate":"2010-04","conditions":"Bladder Cancer","enrollment":3},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT01882166","phase":"NA","title":"Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2013-10","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT02625519","phase":"PHASE4","title":"Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":180},{"nctId":"NCT03480412","phase":"","title":"Second Step Protocol in Poor Ovarian Responder (POR)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-09-01","conditions":"Infertility, Female, Premature Ovarian Failure, Fertility Disorders","enrollment":50},{"nctId":"NCT02148393","phase":"NA","title":"Implantation Enhancement by Elective Cryopreservation of All Viable Embryos","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2014-05","conditions":"Infertility, OHSS","enrollment":212},{"nctId":"NCT02469805","phase":"PHASE3","title":"Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Subfertility","enrollment":450},{"nctId":"NCT02099214","phase":"NA","title":"Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2014-11-05","conditions":"Myocardial Iron Overload, HFE-Associated Hereditary Hemochromatosis","enrollment":66},{"nctId":"NCT01205555","phase":"NA","title":"Combining LHu With Ultrasound Monitoring in IUI","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2010-11-15","conditions":"Infertility","enrollment":367},{"nctId":"NCT02470169","phase":"PHASE3","title":"Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Subfertility","enrollment":450},{"nctId":"NCT02897401","phase":"NA","title":"Determination of Carcinogens Nicotine in Electronic Cigarettes Users","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-09","conditions":"Smoking, Carcinogenesis of the Nicotine","enrollment":80},{"nctId":"NCT02461173","phase":"PHASE3","title":"Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Infertility","enrollment":450},{"nctId":"NCT02700789","phase":"","title":"Pregnancies of Uncertain Location or Viability Research","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2015-01","conditions":"Intrauterine Pregnancy, Ectopic Pregnancy","enrollment":79},{"nctId":"NCT02333253","phase":"PHASE3","title":"Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-01","conditions":"Other Complications Associated With Artificial Fertilization","enrollment":60},{"nctId":"NCT00415766","phase":"PHASE4","title":"Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2013-06","conditions":"Infertility","enrollment":150},{"nctId":"NCT01653743","phase":"PHASE3","title":"Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-09","conditions":"Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction","enrollment":81},{"nctId":"NCT01206803","phase":"","title":"Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-09","conditions":"Infertility, Subfertility","enrollment":294},{"nctId":"NCT02638285","phase":"PHASE4","title":"Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2009-01","conditions":"Pregnancy","enrollment":86},{"nctId":"NCT00953628","phase":"PHASE4","title":"Endometrial Advancement After Rec or u-HCG Triggering","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2005-08","conditions":"Infertility","enrollment":130},{"nctId":"NCT02288143","phase":"PHASE4","title":"COmbining Oral Letrozole and Clomiphene for Ovarian Stimulation","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2015-01","conditions":"Infertility","enrollment":28},{"nctId":"NCT01204840","phase":"PHASE2","title":"Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ottawa Fertility Centre","startDate":"2010-09","conditions":"Infertility, Poor Ovarian Reserve","enrollment":38},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT02251925","phase":"PHASE3","title":"Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2012-09","conditions":"Infertility","enrollment":460},{"nctId":"NCT01504139","phase":"PHASE4","title":"The Luteal Phase After GnRHa Trigger - a Proof of Concept Study","status":"COMPLETED","sponsor":"Regionshospitalet Viborg, Skive","startDate":"2012-01","conditions":"Progesterone Levels, Infertility","enrollment":93},{"nctId":"NCT02310074","phase":"PHASE4","title":"Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2010-01","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":76},{"nctId":"NCT01279200","phase":"PHASE4","title":"Use of High Cost Monitoring During Letrozole Ovulation Induction","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2011-01","conditions":"Infertility","enrollment":21},{"nctId":"NCT01827995","phase":"PHASE4","title":"Simplified Medical Abortion in Rural India","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-04","conditions":"Pregnancy","enrollment":731},{"nctId":"NCT01081756","phase":"PHASE3","title":"A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2003-12","conditions":"Infertility","enrollment":218},{"nctId":"NCT01507376","phase":"PHASE3","title":"Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2010-10","conditions":"In Vitro Fertilization","enrollment":180},{"nctId":"NCT01735422","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"1999-12","conditions":"Infertility","enrollment":67},{"nctId":"NCT01623570","phase":"NA","title":"Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP","status":"COMPLETED","sponsor":"Centro Riproduzione e Andrologia","startDate":"2011-03","conditions":"Hypogonadotropic Hypogonadism","enrollment":40},{"nctId":"NCT00656201","phase":"PHASE4","title":"Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2003-07","conditions":"Infertility","enrollment":468},{"nctId":"NCT01219153","phase":"PHASE2","title":"Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET","status":"COMPLETED","sponsor":"Cairo University","startDate":"2008-09","conditions":"Infertility","enrollment":136},{"nctId":"NCT01220791","phase":"PHASE4","title":"Methylprednisolone Addition in IVF Treatment of Infertile Couples","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2009-01","conditions":"In Vitro Fertilization","enrollment":130},{"nctId":"NCT01191710","phase":"PHASE4","title":"Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2007-01","conditions":"Pregnancy Outcome After In Vitro Fertilization (IVF)","enrollment":200},{"nctId":"NCT00954265","phase":"PHASE3","title":"Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG)","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2005-08","conditions":"Embryonic Development, Pregnancy, VEGF","enrollment":130}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":282,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Profasi"],"phase":"phase_3","status":"active","brandName":"Urinary-hCG","genericName":"Urinary-hCG","companyName":"Merck KGaA, Darmstadt, Germany","companyId":"merck-kgaa-darmstadt-germany","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Urinary-hCG is a human chorionic gonadotropin (hCG) derived from urine that stimulates hormone production in reproductive tissues. Used for Hypogonadism in males, Infertility associated with hypogonadotropic hypogonadism, Ovulation induction in females with infertility.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}